Entering text into the input field will update the search result below

Opexa Therapeutics reports FY results

Feb. 23, 2015 6:24 AM ETAcer Therapeutics Inc. (ACER) StockBy: Gaurav Batavia, SA News Editor
  • Opexa Therapeutics (OPXA): FY14 EPS of -$0.54
  • Revenue of $1.27M (flat Y/Y)
  • Press Release

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
ACER--
Acer Therapeutics Inc.